BAY81-8781, I.V. Aspirin in the Indication of Acute Coronary Syndrome (ACS)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2011
The objective of this study is to investigate whether intravenous administration (injected into a vein) of acetylsalicylic acid (Aspirin) in doses of 250 and 500 mg is superior to oral treatment of ACS with tablets containing 300 mg of Aspirin.
Epistemonikos ID: a3ed50675cb45d6c9b9f22014f2d268020dcdd4b
First added on: May 05, 2024